Regulatory28 Aug 2026, 08:10 pm
Mukka Proteins Gets NSE/BSE In-Principle Approval for Warrant Issue
AI Summary
Mukka Proteins Limited has received in-principle approval from the National Stock Exchange (NSE) and BSE Limited (BSE) for the preferential issue and allotment of 2,00,00,000 convertible warrants to non-promoter category shareholders. Each warrant has an issue price of ₹23.50. This approval is subject to compliance with SEBI regulations and other applicable laws. The company has been advised to strengthen internal controls before allotment.
Key Highlights
- In-principle approval received from NSE and BSE.
- Proposed preferential issue of 2 crore convertible warrants.
- Warrants to be issued to non-promoter category.
- Issue price fixed at ₹23.50 per warrant.
- Subject to regulatory compliance and conditions.
Price Impact
More from MUKKA